Fundamentals of Liver Disease - Abnormal Liver Tests 2.0
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
  • Description
  • Learning Objectives
  • Disclosure of Conflicts of Interest
  • Recommended
Currently, there is an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.
The overall goal is to improve patient care by increasing learner competence and confidence in both proper patient identification and assessment and increasing learner performance in therapeutic options and on-treatment management strategies for patients. Patient outcomes will be improved as a result of the improvements in more providers understanding these key components in the management and care of patients with liver diseases.
· Discuss normal liver function and anatomy.
· Identify routine liver tests, when to order and how to interpret results.
· Recognize acute hepatocellular injury and cholestatic injury based on liver tests results.
· Recognize chronic hepatocellular injury and chronic cholestatic injury based on liver tests results.
· Describe outcomes for patients with abnormal liver tests.
AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosures are collected prior to the start of the educational activity. Any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.

The enduring material organizers, faculty, reviewers and staff have reported the following disclosures:
Tamara H. Taddei, MD, FAASLD
Faculty
Grant/research support: Bayer Healthcare Pharmaceuticals Consulting: Onyx Pharmaceuticals

Hugo E. Vargas, MD, FAASLD
Faculty
Nothing to disclose

Oren K. Fix, MD, MSc, FAASLD
Faculty
Nothing to disclose

Victor J. Navarro, MD, MHCM, FAASLD
Faculty
Nothing to disclose

Manal F. Abdelmalek, MD, MPH
Faculty
Grant/research support: Gilead Sciences, TaiwanJ, NGM, Bristol-Myers Squibb, Genfit, Allergan, Madrigal, Conatus, Boehringer-Ingelhiem, Promethues, Galmed, Novartis, Enanta and Intercept Pharmaceuticals Consulting: TaiwanJ, Bristol-Myers Squibb, Siemens Heathineers, Prometic, and Inventiva

Cynthia Levy, MD, FAASLD
Faculty
Grant/research support: Gilead Sciences, Intercept, CymaBay, Novartis, GSK, Lilly, Enanta, Genkyotex, Genfit, Durect, HighTide, Alnylam Consulting: Cara Therapeutics, Target PharmaSolutions, Pliant, GSK Associate Editor: Liver Transplantation Royalities up-to-date

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Faculty
Honoraria and research support: Janssen Pharmaceuticals, Gilead Sciences, Spring Bank, Intercept, Anylam, Pfizer and Novartis

Meena B. Bansal, MD, FAASLD
Faculty
Nothing to disclose

Sanjeeva Arora, MD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Lauren A. Beste, MD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Amanda J. Chaney, DNP, APRN, FNP-BC
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Royalities: Springer Publishing-Author

Guadalupe Garcia-Tsao, MD, FAASLD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Advisory Board: Intercept, Conatus Scientific Consultant/Advisor to Industry or Commercial Enterprises, including Development of Education Presentations: Conatus, Galectin Research Grants: Intercept

Leslie Hayes
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Minhhuyen Nguyen, MD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Vicki Shah, PA
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Scientific Consultant/Advisory to Industry or Commercial Enterprise, including Development of educational Presentations: Gilead, Intercept, AbbVie Advisory Board, Gilead Advisory Board

Raj Vuppalanchi, MD, FAASLD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Data Safety Monitoring Board for Industry or Commercial Enterprise: Enanta, Covence

Susan Zapatka, MSN
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose Dominique Clayton AASLD Staff Nothing to disclose

Janeil Klett
AASLD Staff
Nothing to disclose

Denise Seise
AASLD Staff
Nothing to disclose

Sheryl Morgan
Amedco LLC Staff
Nothing to disclose

Amanda Cheung
Reviewer 2024
Nothing to disclose

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Acknowledgement of Commercial Support:
No commercial support was received for this enduring material activity.
Powered By